Verfahren zur Detektion von Mutationen in den Genen IL28B (RS8099917) und ITPA (RS1127354)
Anmelder: ARKRAY, Inc. 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP2570492
- Aktenzeichen
- EP12184426
- Anmeldetag
- 14. September 2012
- Veröffentlichung
- 16. Juli 2014
- Erteilung
- 16. Juli 2014
- Rechtsraum
- EP
- IPC
- C12Q1/68
Abstract
A probe for detecting a polymorphism in the IL28B gene, comprising the fluorescently labeled oligonucleotide P1 or P1' below: (P1) an oligonucleotide comprising a nucleotide sequence of 7 to 28 consecutive nucleotides containing nucleotides 301 to 307 in SEQ ID NO:1 or a homologous sequence thereof, wherein the nucleotide corresponding to the nucleotide at position 307 is a cytosine and is labeled with a fluorescent dye; (P1') an oligonucleotide comprising a nucleotide sequence of 7 to 28 consecutive nucleotides containing nucleotides 301 to 307 in SEQ ID NO:1 or a nucleotide sequence which hybridizes with the complementary strand of SEQ ID NO:1 under stringent conditions, wherein the nucleotide corresponding to the nucleotide at position 307 is a cytosine and is labeled with a fluorescent dye. A probe for detecting a polymorphism in the ITPA gene, comprising at least one fluorescently labeled oligonucleotide selected from P2 to P3' below: (P2) an oligonucleotide comprising a complement of a nucleotide sequence of 13 to 28 consecutive nucleotides containing nucleotides 239 to 251 in SEQ ID NO:2 or a homologous sequence thereof, wherein the nucleotide corresponding (i.e. complementary) to the nucleotide at position 239 is a cytosine and is labeled with a fluorescent dye; (P2') an oligonucleotide comprising a nucleotide sequence which hybridizes with a nucleotide sequence of 13 to 28 consecutive nucleotides containing nucleotides 239 to 251 in SEQ ID NO:2 under stringent conditions, wherein the nucleotide corresponding (i.e. complementary) to the nucleotide at position 239 is a cytosine and is labeled with a fluorescent dye; (P3) an oligonucleotide comprising a nucleotide sequence of 6 to 42 consecutive nucleotides containing nucleotides 251 to 256 in SEQ ID NO:2 or a homologous sequence thereof, wherein the nucleotide corresponding to the nucleotide at position 256 is a cytosine and is labeled with a fluorescent dye; (P3') an oligonucleotide comprising a nucleotide sequence of 6 to 42 consecutive nucleotides containing nucleotides 251 to 256 in SEQ ID NO:2 or a nucleotide sequence which hybridizes with the complementary strand of SEQ ID NO: 2 under stringent conditions, wherein the nucleotide corresponding to the nucleotide at position 256 is a cytosine and is labeled with a fluorescent dye.
Anmelder
- Firma
- ARKRAY, Inc.
- Land
- 🇯🇵 Japan
Japanisches Unternehmen mit Sitz in Kyoto, das medizinische Diagnosegeräte herstellt, insbesondere Blutzuckermessgeräte und klinische Labordiagnostik.
793 Patente in unserer Datenbank